Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany.


Journal

International journal of medical microbiology : IJMM
ISSN: 1618-0607
Titre abrégé: Int J Med Microbiol
Pays: Germany
ID NLM: 100898849

Informations de publication

Date de publication:
Historique:
received: 11 12 2018
revised: 18 02 2019
accepted: 04 03 2019
pubmed: 19 3 2019
medline: 5 9 2019
entrez: 19 3 2019
Statut: ppublish

Résumé

Clostridium (Clostridioides) difficile is the main cause of nosocomial diarrhoea. Ribotype 018 (RT018) has been recognized as the predominant strain responsible for C. difficile infection (CDI) in Italy, whereas in most other European countries only sporadic RT018 cases occur. Between August and October 2015, a suspected C. difficile outbreak at two associated hospitals in Southern Germany was investigated by comprehensive molecular typing. Surprisingly, RT018 was detected in 9/82 CDI patients, which has never been described before in a German outbreak. Phenotypic analysis revealed fluoroquinolone and macrolide resistance. Genetic subtyping using multiple-locus variable-number tandem-repeat analysis (MLVA) and whole genome sequencing (WGS) was performed and outbreak isolates were directly compared to sporadic German RT018 isolates and to epidemic ones from Milan, Northern Italy. Molecular typing confirmed a hospital outbreak with closely related RT018 isolates. Both, MLVA and WGS revealed high similarity of outbreak strains with epidemic isolates from Italy, but low similarity to other German isolates. Comparison between both typing strategies showed that ribotyping in combination with MLVA was appropriate to identify related isolates and clonal complexes, whereas WGS provided a better discrimination with more detailed information about the phylogenetic relationship of isolates. This is the first hospital outbreak in Germany presumably caused by cross-national transmission of an Italian epidemic RT018 strain.

Identifiants

pubmed: 30879971
pii: S1438-4221(18)30613-1
doi: 10.1016/j.ijmm.2019.03.001
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Toxins 0
DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-193

Informations de copyright

Copyright © 2019 Elsevier GmbH. All rights reserved.

Auteurs

Fabian K Berger (FK)

Institute of Medical Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Saarland University, Kirrberger Straße, Building 43, 66421 Homburg, Saar, Germany. Electronic address: fabian.berger@uks.eu.

Sabine Gfrörer (S)

Regionale Kliniken Holding RKH GmbH, Ludwigsburg, Germany.

Sören L Becker (SL)

Institute of Medical Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Saarland University, Kirrberger Straße, Building 43, 66421 Homburg, Saar, Germany; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, P.O. Box, CH-4003 Basel, Switzerland.

Rossella Baldan (R)

Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Via Olgettina Milano 60, 20132 Italy.

Daniela Maria Cirillo (DM)

Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Via Olgettina Milano 60, 20132 Italy.

Martinique Frentrup (M)

Leibniz Institute DSMZ, Inhoffenstraße 7B, 38124 Braunschweig, Germany.

Matthias Steglich (M)

Leibniz Institute DSMZ, Inhoffenstraße 7B, 38124 Braunschweig, Germany; German Centre for Infection Research (DZIF), Partner site Braunschweig-Hannover, Inhoffenstraße 7, 38124 Braunschweig, Germany.

Pit Engling (P)

Leibniz Institute DSMZ, Inhoffenstraße 7B, 38124 Braunschweig, Germany.

Ulrich Nübel (U)

Leibniz Institute DSMZ, Inhoffenstraße 7B, 38124 Braunschweig, Germany; German Centre for Infection Research (DZIF), Partner site Braunschweig-Hannover, Inhoffenstraße 7, 38124 Braunschweig, Germany; Braunschweig Integrated Centre of Systems Biology (BRICS), Technical University Braunschweig, Rebenring 56, 38106 Braunschweig, Germany.

Alexander Mellmann (A)

Institute of Hygiene, University Hospital Münster, National Reference Centre for Clostridium difficile, Robert-Koch-Straße 41, 48149 Münster, Germany.

Markus Bischoff (M)

Institute of Medical Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Saarland University, Kirrberger Straße, Building 43, 66421 Homburg, Saar, Germany.

Barbara Gärtner (B)

Institute of Medical Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Saarland University, Kirrberger Straße, Building 43, 66421 Homburg, Saar, Germany.

Lutz von Müller (L)

Institute of Medical Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Saarland University, Kirrberger Straße, Building 43, 66421 Homburg, Saar, Germany; Institute for Laboratory Medicine, Microbiology and Hygiene, National Reference Centre for Clostridium difficile, Christophorus Kliniken, Südwall 22, 48653 Coesfeld, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH